Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Microbiota and child health
  3. Zoom on the risks of IBD
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Microbiota and child health
  3. Zoom on the risks of IBD
Pediatrics

Zoom on the risks of IBD

IBD
Pediatrics

There is an increased risk of Inflammatory Bowel Disease (IBD) in young children who have been exposed intrapartum to antibiotics. The physiological disruptions caused by dysbiosis, in particular within the intestinal mucosa and the immune system, facilitate the development of this type of rare inflammatory diseases.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Created 18 October 2019
Updated 27 October 2021

EXPOSURE TO ANTIBIOTICS AND EARLY IBD

The excess weight issue underlines the complexity in elucidating the impact of dysbiosis in some medical fields. Causal relations have been more detailed in the gastroenterology field, where a link has been established between the composition of the intestinal microbiota and IBD. This connection leads researchers to increasingly take dysbioses into account when attempting to understand disorders with poorly identified etiology, especially ulcerative colitis (UC) and Crohn’s Disease in young children (under six years of age), whose global incidence is increasing regularly. As the cause of this progression cannot be found in known genetic and environmental factors, intestinal weakness associated with disruptions in the microbiota has been suggested.

TWOFOLD HIGHER RISK OF IBD AFTER INTRAPARTUM ANTIBIOTIC TREATMENT

Swedish researchers explored this hypothesis by studying a cohort of 827,239 children born between 2006 and 2013.3 This was an extensive analysis based on crosschecking the Swedish National Registers of births, patients and drug prescriptions. In total, 17% of subjects were exposed intrapartum to antibiotics (including 5% repeatedly) and 65% after birth, most of them more than once (7 out of 10). Fifty-one children were affected by Crohn’s disease or UC. Compared to the control population, children exposed to antibiotics during pregnancy had an elevated risk (aHR4 = 1.93) of developing early IBD.

FETAL IMPACT

Intrauterine exposure to antibiotics is believed to trigger a disruption of early bacterial colonization in children, characterized by a low concentration of commensal bacteria, in particular Faecalibacterium prausnitzii and Ruminococcaceae, and an increase in pathogenic bacteria. This dysbiosis could cause significant physiological changes due to the interaction between microbiota and host through production of SCFA (particularly butyrate), induction of the immune system of the intestinal mucosa, stimulation of the local nervous system and maintenance of the intestinal barrier function.5 These are all malfunctions which are liable to trigger inflammatory disorders.

IMPROVING ANTIBIOTIC PRESCRIPTION TO PRESERVE THE MICROBIOTA

The data mentioned above and those derived from a growing number of studies and publications show that a diversified microbiota displaying a high commensal/pathogenic bacteria ratio contributes to an adequate development in children by limiting the risk of occurrence of some diseases, especially metabolic or inflammatory. This observation should not lead to a dismissal of antibiotic therapy, whose efficacy and benefits prove invaluable in many cases, as emphasized by all healthcare providers. However, optimizing prescriptions, spectrum of the drugs employed, duration of treatment and modes of administration are good ways of limiting the impact of antibiotics and the transfer of resistance to the intestinal microbiota in order to preserve child health in the short and long term.

Image
Focus-risk-IBD-infographie-1
Sources

3 Örtqvist AK, Lundholm C, Halfvarson J, et al. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut. 2019;68(2):218-225.

4 Ajusted Hazard Ratio

5 Short-chain fatty acids. They are products of carbohydrate fermentation (organic anions and saturated fatty acids) carried out by anaerobic bacteria in the colon.

6 Rasmussen SH, Shrestha S, Bjerregaard LG, et al. Antibiotic exposure in early life and childhood overweight and obesity: A systematic review and meta-analysis. Diabetes Obes Metab. 2018;20(6):1508-1514.

Old sources

 

 

Tags
Dysbiosis Gut health Antibiotics Microbiome Flora
    Focus
    Microbiota and child health
    • Impact of antibiotics
      • Antibiotics, child microbiota and long-term health effects
      • Focus on the risks of excess weight and obesity
      • Zoom on the risks of IBD
    • Behavioral disorders
      • The role of oral and intestinal microbiota and mycobiome in autism
      • Gut-brain axis and ADHD in adolescents
    • Respiratory diseases
      • Respiratory microbiota and pulmonary infections associated with cystic fibrosis
      • Nasal microbiota: a reliable marker of bronchiolitis severity
    • Gastrointestinal disorders
      • Infectious diarrhea and intestinal microbiota
      • Is intestinal dysbiosis the cause of persistent diarrhea?
    • Expert opinion
      • Pr. Olivier Goulet : Gastrointestinal disorders in children, the need to act
    Created 18 October 2019
    Updated 27 October 2021

    About this article

    To know more about this topic.

    Main topic

    IBD

    Medical practice

    Pediatrics

    Content type

    Dossier detail
    Focus on the risks of excess weight and obesity
    The role of oral and intestinal microbiota and mycobiome in autism
    Focus

    Microbiota and child health

    Impact of antibiotics

    Antibiotics, child microbiota and long-term health effects Focus on the risks of excess weight and obesity Zoom on the risks of IBD

    Behavioral disorders

    The role of oral and intestinal microbiota and mycobiome in autism Gut-brain axis and ADHD in adolescents

    Respiratory diseases

    Respiratory microbiota and pulmonary infections associated with cystic fibrosis Nasal microbiota: a reliable marker of bronchiolitis severity

    Gastrointestinal disorders

    Infectious diarrhea and intestinal microbiota Is intestinal dysbiosis the cause of persistent diarrhea?

    Expert opinion

    Pr. Olivier Goulet : Gastrointestinal disorders in children, the need to act
    Pediatrics
    Actu PRO : Malnutrition : agir sur le microbiote pour améliorer la croissance, un prototype à l’essai
    08.07.2021

    Malnutrition: acting on the microbiota in order to improve growth, a trial prototype

    Read the article
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article
    Everything you need to know about Microbiota & Immunity
    15.09.2022

    Everything you need to know about Microbiota & Immunity

    Read the article
    Everything you need to know about Microbiota & Dysbiosis
    27.07.2022

    Everything you need to know about Dysbiosis

    Read the article
    11.03.2022

    When an infant’s sleep hinges on a few bacteria

    Read the article
    03.07.2024

    Gut dysbiosis in men: what are the consequences for their children?

    Read the article
    Photo: Atténuer la dénutrition avec des biotiques ?
    26.04.2023

    Mitigating malnutrition with biotics?

    Read the article
    Intestinal bacteria, illustration.
    24.08.2023

    Everything you need to know about probiotics

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo